
-
FIFPro warns of 'wake-up call' over extreme heat at Club World Cup
-
Sean Combs sex trafficking jury ends first day without decision
-
Fluminense stun Inter Milan to reach Club World Cup quarters
-
Thailand's ruling political dynasty faces day of legal peril
-
NASA eyes summer streaming liftoff on Netflix
-
Trump dismantles Syria sanctions program as Israel ties eyed
-
Meta's AI talent war raises questions about strategy
-
Twenty bodies, some headless, found in Mexican cartel bastion
-
Gaza rescuers say Israeli forces kill over 50 as ceasefire calls mount
-
Alcaraz survives scare, Sabalenka cruises on Wimbledon's hottest opening day
-
Only Messi can shirk defending: warns Monterrey coach before Dortmund clash
-
White House says Canada 'caved' to Trump on tech tax
-
Eight-country coalition aims to tax luxury air travel
-
Wimbledon qualifier Tarvet vows to get creative with expenses
-
Iran unleashes 'wave of repression' after Israel war: activists
-
Alcaraz survives Fognini scare to launch Wimbledon title defence
-
Peace deal with Rwanda opens way to 'new era', says DR Congo president
-
Kneecap, Bob Vylan Glastonbury sets spark police probe and global criticism
-
'Starvation' days over as cyclists prepare to gorge on Tour de France
-
Gaza rescuers say Israeli forces kill 48 as ceasefire calls mount
-
Sabalenka boosted by hitting with Djokovic and Sinner at Wimbledon
-
Nigeria theme park offers escape from biting economy
-
Jury considers verdict in Sean Combs sex trafficking trial
-
Wall Street stocks rally further on trade and tax deal optimism
-
Sabalenka cruises on Wimbledon's hottest opening day as Alcaraz launches title bid
-
Bosch breaks through as South Africa set Zimbabwe huge target
-
S.Africa's ex-transport bosses charged over Zuma-era graft case
-
'No panic' says Medvedev after shock Wimbledon exit
-
Rescuers evacuate 50,000 as Turkey battles wildfires
-
ADB acting on US concerns over China, bank chief tells AFP
-
Archer misses out as England unchanged for second India Test
-
US Senate begins nail-biting vote on Trump spending bill
-
Top seed Sabalenka cruises into Wimbledon second round
-
Medvedev suffers shock early Wimbledon exit
-
Wall Street stocks rally further on trade deal optimism
-
Britain's Tarvet says 'not here for the money' after landmark Wimbledon win
-
Tennis fans sizzle as heatwave hits Wimbledon
-
Tearful Jabeur forced to retire from Wimbledon first-round clash
-
No relief for Southern Europe as punishing heatwave persists
-
PKK disarmament process to begin early July: report
-
Alcaraz, Sabalenka in action on day one at sizzling Wimbledon
-
France court jails migrant smugglers over 2022 Channel deaths
-
Stocks muted as investors eye US trade talks
-
China says aircraft carriers conduct combat training in Pacific
-
NGO loses bid to block UK export of military equipment to Israel
-
Three talking points from Austrian Grand Prix
-
Wimbledon 'ready' for soaring temperatures
-
UN chief urges aid surge in world of 'climate chaos, raging conflicts'
-
French injury worries mount ahead of first All Blacks Test
-
India coach Gambhir faces growing pressure ahead of second England Test

Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN